A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy

Mesenchymal stem cells (MSCs) driven gene-directed enzyme prodrug therapy has emerged as a potential strategy for cancer treatment. The tumour-nesting properties of MSCs enable these vehicles to target tumours and metastases with effective therapies. A crucial step in engineering MSCs is the deliver...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Yoon Khei, Woo, Jun Yung, Tu, Geraldine Xue En, Deng, Lih-Wen, Too, Heng-Phon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458920/
https://www.ncbi.nlm.nih.gov/pubmed/32868813
http://dx.doi.org/10.1038/s41598-020-71224-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458920/
https://www.ncbi.nlm.nih.gov/pubmed/32868813
http://dx.doi.org/10.1038/s41598-020-71224-2

Ejemplares similares